Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
BIOTECHNOLOGY VALUE FUND L P - 31 Dec 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)
- Filing Manager
- BIOTECHNOLOGY VALUE FUND L P
- Reporting Manager
- BVF PARTNERS L P/IL
- Symbol
- CGEM
- Shares outstanding
- 59,244,054 shares
- Disclosed Ownership
- 5,918,481 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:10:11 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (10)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.6% | 3,302,376 | 0 | 3,302,376 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 5.6% | 3,302,376 | 0 | 3,302,376 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.8% | 2,271,662 | 0 | 2,271,662 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.8% | 2,271,662 | 0 | 2,271,662 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 224,641 | 0 | 224,641 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 224,641 | 0 | 224,641 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.4% | 5,574,038 | 0 | 5,574,038 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 5,918,481 | 0 | 5,918,481 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 5,918,481 | 0 | 5,918,481 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 5,918,481 | 0 | 5,918,481 | /s/ Mark N. Lampert | Mark N. Lampert |